Reproducibility and cell biology

![Figure][1] © Sidney Harris The New Yorker Collection/The Cartoon Bank Growing concerns about the reproducibility of published research threaten to undermine the scientific enterprise and erode public trust. Conscientious application of “best practices” for the generation and

[1]  Carly Strasser,et al.  Data publication consensus and controversies , 2014, F1000Research.

[2]  F. Prinz,et al.  Believe it or not: how much can we rely on published data on potential drug targets? , 2011, Nature Reviews Drug Discovery.

[3]  C. Begley,et al.  Drug development: Raise standards for preclinical cancer research , 2012, Nature.

[4]  Tom Misteli,et al.  The JCB DataViewer scales up , 2012, The Journal of cell biology.

[5]  J. Brooks.  Why most published research findings are false: Ioannidis JP, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece , 2008 .

[6]  F. Collins,et al.  Policy: NIH plans to enhance reproducibility , 2014, Nature.

[7]  Chris Sander,et al.  Off-target effects dominate a large-scale RNAi screen for modulators of the TGF-β pathway and reveal microRNA regulation of TGFBR2 , 2011, Silence.

[8]  Darjus F. Tschaharganeh,et al.  Non-specific effects of siRNAs on tumor cells with implications on therapeutic applicability using RNA interference , 2007, Pathology & Oncology Research.

[9]  Robert M. Hoffman,et al.  Physical limits of cell migration: Control by ECM space and nuclear deformation and tuning by proteolysis and traction force , 2013, The Journal of cell biology.

[10]  S. Lazic,et al.  A call for transparent reporting to optimize the predictive value of preclinical research , 2012, Nature.

[11]  P. Cohen,et al.  The selectivity of protein kinase inhibitors: a further update. , 2007, The Biochemical journal.

[12]  Irene Kuhn,et al.  Sorting out the FACS: a devil in the details. , 2014, Cell reports.